Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+PD-1lo Effector T Cells

被引:12
|
作者
Goudin, Nicolas [1 ]
Chappert, Pascal [2 ]
Megret, Jerome [1 ]
Gross, David-Alexandre [2 ]
Rocha, Benedita [2 ]
Azogui, Orly [2 ]
机构
[1] CNRS, UMS 3633, INSERM,Struct Federat Rech Necker, US 24,Plateau Tech Cytometrie & Imagerie Cellulai, Paris, France
[2] Univ Paris 05, Sorbonne Paris Cite, CNRS, UMR8253,INSERM,U1151,Inst Necker Enfants Malad,Fa, Paris, France
来源
PLOS ONE | 2016年 / 11卷 / 06期
关键词
DRAINING LYMPH-NODES; IN-VIVO; VIRAL-INFECTION; TUMOR; ANTIGEN; CD8(+); DIFFERENTIATION; TOLERANCE; MICE; PD-1;
D O I
10.1371/journal.pone.0157822
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Natural regulatory T (Treg) cells interfere with multiple functions, which are crucial for the development of strong anti-tumour responses. In a model of 4T1 mammary carcinoma, depletion of CD25(+)Tregs results in tumour regression in Balb/c mice, but the mechanisms underlying this process are not fully understood. Here, we show that partial Treg depletion leads to the generation of a particular effector CD8 T cell subset expressing CD11c and low level of PD-1 in tumour draining lymph nodes. These cells have the capacity to migrate into the tumour, to kill DCs, and to locally regulate the anti-tumour response. These events are concordant with a substantial increase in CD11b(+) resident dendritic cells (DCs) subsets in draining lymph nodes followed by CD8(+) DCs. These results indicate that Treg depletion leads to tumour regression by unmasking an increase of DC subsets as a part of a program that optimizes the microenvironment by orchestrating the activation, amplification, and migration of high numbers of fully differentiated CD8(+)CD11c(+)PD1(lo) effector T cells to the tumour sites. They also indicate that a critical pattern of DC subsets correlates with the evolution of the anti-tumour response and provide a template for Treg depletion and DC-based therapy.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Protective low-avidity anti-tumour CD8+T cells are selectively attenuated by regulatory T cells
    Sugiyarto, Gessa
    Prossor, David
    Dadas, Osman
    Arcia-Anaya, E. David
    Elliott, Tim
    James, Edward
    IMMUNOTHERAPY ADVANCES, 2021, 1 (01):
  • [2] Mesenteric lymph node CD11b- CD103+ PD-L1High dendritic cells highly induce regulatory T cells
    Shiokawa, Aya
    Kotaki, Ryutaro
    Takano, Tomohiro
    Nakajima-Adachi, Haruyo
    Hachimura, Satoshi
    IMMUNOLOGY, 2017, 152 (01) : 52 - 64
  • [3] PD-L1 is expressed on human activated naive effector CD4+ T cells. Regulation by dendritic cells and regulatory CD4+ T cells
    Mazerolles, Fabienne
    Rieux-Laucat, Frederic
    PLOS ONE, 2021, 16 (11):
  • [4] Induction of CD4+ Regulatory and Polarized Effector/helper T Cells by Dendritic Cells
    Lutz, Manfred B.
    IMMUNE NETWORK, 2016, 16 (01) : 13 - 25
  • [5] CD4+CD25+T regulatory cells limit effector T cells and favor the progression of brucellosis in BALB/c mice
    Pasquali, Paolo
    Thornton, Angela M.
    Vendetti, Silvia
    Pistoia, Claudia
    Petrucci, Paola
    Tarantino, Michela
    Pesciaroli, Michele
    Ruggeri, Franco
    Battistoni, Andrea
    Shevach, Ethan M.
    MICROBES AND INFECTION, 2010, 12 (01) : 3 - 10
  • [6] Gap junctions between regulatory T cells and dendritic cells prevent sensitization of CD8+ T cells
    Ring, Sabine
    Karakhanova, Svetlana
    Johnson, Theron
    Enk, Alexander H.
    Mahnke, Karsten
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (01) : 237 - 246
  • [7] Tolerogenic Dendritic Cells Induce CD4+CD25hiFoxp3+ Regulatory T Cell Differentiation from CD4+CD25-/loFoxp3- Effector T Cells
    Huang, Hui
    Dawicki, Wojciech
    Zhang, Xiaobei
    Town, Jennifer
    Gordon, John R.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09) : 5003 - 5010
  • [8] CD8α+ dendritic cells prime TCR-peptide-reactive regulatory CD4+FOXP3- T cells
    Smith, Trevor R. F.
    Maricic, Igor
    Ria, Francesco
    Schneider, Susan
    Kumar, Vipin
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (07) : 1906 - 1915
  • [9] The opposing roles of CD4+ T cells in anti-tumour immunity
    Ahrends, Tomasz
    Borst, Jannie
    IMMUNOLOGY, 2018, 154 (04) : 582 - 592
  • [10] The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells
    Ye, Lin-Lin
    Wei, Xiao-Shan
    Zhang, Min
    Niu, Yi-Ran
    Zhou, Qiong
    FRONTIERS IN IMMUNOLOGY, 2018, 9